Synthesis and Biological Activity of Pyridopyridazine Derivatives: A Mini Review

Author(s): Anna Wojcicka*, Anna Nowicka-Zuchowska.

Journal Name: Mini-Reviews in Organic Chemistry

Volume 16 , Issue 1 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

This review presents most of the literature data about synthesis and biological activity of pyridopyridazine derivatives. There are six structural isomers of the bicyclic ring system containing pyridine moiety condensed with pyridazine nucleus. Pyridopyridazine derivatives show antitumor, antibacterial, analgesic and diuretics activities. The derivatives have been identified as the selective phosphodiesterase 5 and phosphodiesterase 4 inhibitors. Pyridopyridazines are novel class of GABA-A receptor benzodiazepine binding site ligands. Some of pyrido[3,2-c]pyridazine derivatives possess molluscicidal activity and can be used as biodegradable agrochemicals. The broad spectrum of biological activity of pyridopyridazine derivatives is the main reason for the preparation of new compounds containing this scaffold.

Keywords: Biological activity, pyrido[3, 4-c]pyridazines, pyrido[3, 4-d]pyridazines, pyrido[3, 2-c]pyridazines, pyrido[2, 3- c]pyridazines, pyrido[2, 3-d]pyridazines, pyrido[4, 3-c]pyridazines, synthesis.

[1]
Tomita, K.; Tsuzuki, Y.; Shibamori, K.; Tashima, M.; Kajikawa, F.; Sato, Y.; Kashimoto, S.; Chiba, K.; Hino, K. Synthesis and structure-activity relationships of novel 7-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids as antitumor agents. Part 1. J. Med. Chem., 2002, 45, 5564-5575.
[2]
Kaizerman, J.; Lucas, B.; McMinn, D.; Zmboni, R. Pyridopyridazine compounds, compositions and methods of use. US0099173 A1, 2009.
[3]
Kaizerman, J.A.; Aaron, W.; An, S.; Austin, R.; Brown, M.; Chong, A.; Lee, G. Addressing PXR liabilities of phthalazine-based hedgehog/smoothened antagonists using novel pyridopyridazines. Bioorg. Med. Chem. Lett., 2010, 20(15), 4607-4610.
[4]
Bold, G.; Altmann, K.H.; Frei, J.; Lang, M.; Manley, P.W.; Traxler, P.; Wietfeld, B.; Brüggen, J.; Buchdunger, E.; Cozens, R.; Ferrari, S.; Furet, P.; Hofmann, F.; Martiny-Baron, G.; Mestan, J.; Rösel, J.; Sills, M.; Stover, D.; Acemoglu, F.; Boss, E.; Emmenegger, R.; Lässer, L.; Masso, E.; Roth, R.; Schlachter, C.; Vetterli, W.; Wyss, D.; Wood, J.M. New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis. J. Med. Chem., 2000, 43, 2310-2323.
[5]
Kumar, V.; Sanna, V.K.; Singh, A.T.; Jaggi, M.; Sharma, P.K.; Irchhaiya, R.; Burman, A.C. Synthesis and anti-cancer activity of pyrido[2,3-c]pyridazine derivatives. J. Sci. Islam. Repub. Iran, 2009, 20, 325-329.
[6]
El-Sharkawy, K.A.; Ibrahim, R.A. New approaches for the synthesis and antitumor evaluation of pyridine, thieno[3,4-c]pyridine, pyrazolo[3,4-b]pyridine and pyrido[3,4-d]pyridazine derivatives. Eur. Chem. Bull., 2013, 2(8), 530-537.
[7]
Cobo, J.; Sanchez, A.; Nougueras, M. Synthesis and antiviral evaluation of pyridine fused heterocyclic and nucleosidic derivatives. Tetrahedron, 1997, 53, 8225-8236.
[8]
Miyamoto, T.; Matsumoto, J. Fluorinated pyrido [2, 3-c]pyridazines. ii. synthesis and antibacterial activity of 1, 7-disubstituted 6-fluoro-4 (1h)-oxopyrido [2, 3-c]pyridazine-3-carboxylic acids. Chem. Pharm. Bull., 1990, 38, 3359-3365.
[9]
Stanasiuk, J. Investigations on the synthesis and properties of 2-(alkyl,aryl)-1,4,5-trioxo-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyrida-zines, derivatives with potential biological activity. Acta Pol. Pharm., 2006, 63, 420-421.
[10]
Fadda, A.A.; Rabie, R.R.; Bondock, S.; Etman, H.A. Derivational, structural, and biological studies of some new pyrazolyl, isoxazolyl, pyrimidynyl, pyridazinyl, and pyridopyridazinyl from 4-substituted antipyrine. J. Heterocycl. Chem., 2017, 54(2), 1304-1310.
[11]
Elassar, A.Z.A. Synthesis and antimicrobial activity of new polyfunctionally substituted pyridines and their fused derivatives. Indian J. Chem., 2004, 43B, 1314-1319.
[12]
Sladowska, H.; Filipek, B.; Sapa, J.; Sieklucka-Dziuba, M.; Szymanska, M.; Kleinrok, Z.; Sokolowska, M. Synthesis and properties of tetra(hexa)hydropyrazolo[1,2-a]pyrido-[3,4]pyridazine derivatives. Boll. Chim. Farm., 2003, 142(1), 21-27.
[13]
Sladowska, H.; Potoczek, J.; Sieklucka-Dziuba, M.; Rajtar, G.; Mlynarczyk, M.; Kleinrok, Z. Investigations on the synthesis and properties of some N-arylpiperazinylalkyl derivatives of 1,4-dioxo(1,4,5-trioxo)-1,2,3,4-tetra (and 1,2,3,4,5,6-hexa)hydro-pyrido[3,4-d]pyridazines. Farmaco, 1995, 50, 37-46.
[14]
Sladowska, H.; Bodetko, M.; Sieklucka-Dziuba, M.; Rajtar, G.; Zolkowska, D.; Kleinrok, Z. Transformation of some pyrido[2,3-d]pyrimidine derivatives into other di- and triheterocyclic systems. Farmaco, 1997, 52, 657-662.
[15]
Sladowska, H.; Potoczek, J.; Sokolowska, M.; Rajtar, G.; Sieklucka-Dziuba, M.; Kocki, T.; Kleinrok, Z. Investigations on the synthesis and properties of N-phenyl derivatives of 1,4-dioxo(1,4,5-trioxo)-1,2,3,4-tetra(1,2,3,4,5,6-hexa)hydropyrido[3,4-d]pyridazines and allied compounds. Farmaco, 1998, 53, 468-474.
[16]
Sladowska, H.; Stanasiuk, J.; Sieklucka-Dziuba, M.; Saran, T.; Kleinrok, Z. Investigatios on the synthesis and properties of 4-aminosubstituted 2,6,7-trimethyl-1,5-dioxo-1,2,5,6-tetrahydro-pyri-do[3,4-d]pyridazines. Farmaco, 1998, 53, 475-479.
[17]
Sladowska, H.; Potoczek, J.; Rajtar, G.; Sieklucka-Dziuba, M.; Mlynarczyk, M.; Kleinrok, Z. Synthesis and pharmacological evaluation of N-aryl(pyrimidinyl)piperazinylalkyl (hydroksyalkyl) derivatives of 1,2,3,4-tetra- and 1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazines. Farmaco, 1996, 51, 431-436.
[18]
Pakulska, W.; Malinowski, Z.; Szcześniak, A.K.; Czarnecka, E.; Epsztajn, J. Synthesis and pharmacological evaluation of N-(Dimethylamino)ethyl derivatives of benzo- and pyridopyriazinones. Arch. Pharm. Chem. Life Sci, 2009, 342, 41-47.
[19]
Mitchinson, A.; Blackaby, W.P.; Bourrain, S.; Carling, R.W.; Lewis, R.T. Synthesis of pyrido [2, 3-d] pyridazines and pyrazino [2, 3-d]pyridazines-novel classes of GABA a receptor benzodiazepine binding site ligands. Tetrahedron Lett., 2006, 47, 2257-2260.
[20]
Goodacre, S.C.; Hallett, D.J. Substituted pyrido-pyridazine derivatives which enhance cognition via the Gaba-a receptors. US7148222 2006.
[21]
Dong, Z.Q.; Liu, X.M.; Wei, C.X.; Quan, Z.S. Design, synthesis of 6-substituted-pyrido[3,2-d]pyridazine derivatives with anticonvulsant activity. Med. Chem., 2015, 11(6), 595-601.
[22]
Gößnitzer, E.; Krbavcic, A.; Wendelin, W.; Krbavcic, M. Synthesis and structure investigations of potential sedative and anticonvulsant hydroxy-and acetoxy-N-(3-oxobutyl)-pyrido [2, 3-d]pyridazinones. Monatsh. Chem., 2002, 133(9), 1177-1185.
[23]
Oka, Y.; Itoh, K.; Miyake, A.; Tada, N.; Omura, K.; Tomimoto, M.; Yurugi, S. Studies on the syntheses of N-Heterocyclic compounds. XXVI. Syntheses of pyrido[3,4-d]pyridazine derivatives (3). Chem. Pharm. Bull., 1975, 23(10), 2306-2317.
[24]
Oka, Y.; Omura, K.; Miyake, A.; Itoh, K.; Tomimoto, M.; Tada, N.; Yurugi, S. Studies on the syntheses of N-Heterocyclic compounds. XXV. Syntheses of pyrido[3,4-d]pyridazine derivatives (2). Chem. Pharm. Bull., 1975, 23(10), 2239-2250.
[25]
Omura, K.; Tada, N.; Tomimoto, M.; Usui, Y.; Oka, Y.; Yurugi, S. Studies on the syntheses of N-heterocyclic compounds. XXVIII. Syntheses of pyrido[3,4-d]pyridazine derivatives (4). Chem. Pharm. Bull., 1976, 24(11), 2699-2710.
[26]
Yu, G.; Mason, H.; Wu, X.; Wang, J.; Chong, S.; Beyer, B.; Henwood, A.; Pongrac, R.; Seliger, L.; He, B.; Normandin, D.; Ferrer, P.; Zhang, R.; Adam, L.; Humphrey, W.G.; Krupinski, J.; Macor, J.E. Substituted pyrazolopyridopyridazines as orally bioavailable potent and selective PDE5 inhibitors: Potential agents for treatment of erectile dysfunction. J. Med. Chem., 2003, 46, 457-460.
[27]
Dal Piaz, V.; Giovannoni, M.P.; Castellana, C. Novel heterocyclic-fused pyridazinones as potent and selective phosphodiesterase IV inhibitors. J. Med. Chem., 1997, 40, 1417-1421.
[28]
Dal Piaz, V.; Giovannoni, M.P.; Castellana, C.; Palacios, J.M.; Beleta, J.; Domenech, T.; Segarra, V. Heterocyclic-fused 3(2H)-pyridazinones as potent and selective PDE IV inhibitors: Further structure-activity relationships and molecular modelling studies. Eur. J. Med. Chem., 1998, 33, 789-797.
[29]
Pita, B.; Sotelo, E.; Suárez, M.; Raviña, E.; Ochoa, E.; Verdecia, Y.; Peeters, O.M. Pyridazine derivatives. Part 21: Synthesis and structural study of novel 4-aryl-2, 5-dioxo-8-phenylpyrido [2, 3-d]pyridazines. Tetrahedron, 2000, 56(16), 2473-2479.
[30]
Abdelrazek, F.M.; El-Din, A.; Fathyb, M. A novel synthesis and molluscicidal activity of some functionally substituted pyridine, pyrido[3,2-c]pyridazine, and pyrido[3,2-c]pyridazino[2,3-a]quina-zoline derivatives. Arch. Pharm. Chem. Life Sci, 2005, 338, 329-334.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 16
ISSUE: 1
Year: 2019
Page: [3 - 11]
Pages: 9
DOI: 10.2174/1570193X15666180220155119
Price: $65

Article Metrics

PDF: 37
HTML: 3